New Insights on the Impact of IgG4-related Disease
Although ongoing research continues to advance our understanding of IgG4-related disease (IgG4-RD), the epidemiology and downstream consequences of this relatively rare and complex autoimmune ...
Obexelimab: A New Hope for IgG4-RD Treatment?
Exciting results from an open-label Phase 2 pilot trial published in Lancet Rheumatology[1] suggest that obexelimab, a potential new treatment for IgG4-related disease (IgG4-RD), may become an ...
In Conversation With… Wen Zhang, MD PhD
“We have a saying in China, ‘to turn pale at the mention of a tiger’, and this describes the fear many patients show when told they need to be prescribed steroids.” Wen Zhang, MD PhD is a Professor ...
Ruminations on 20 Years of Advances in IgG4-Related Disease Diagnosis and Management
“While there is a growing body of case work on IgG4-related disease, people still find it a revelation that IgG4-related disease is actually a form of vasculitis.” The epidemiology of IgG4-related ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
